Amy Jang, a doctoral candidate at the University of Arizona College of Pharmacy, writes that amid the current pandemic, there is currently no official approved drug indicated to treat patients with coronavirus disease 2019. However, the FDA has temporarily approved certain antiviral medications and anti-inflammatory drugs to use for the emergency treatment of severe acute respiratory syndrome coronavirus 2 to potentially reduce hospitalization rates for infected patients.

Dr. Judith Gordon’s research team develops “See Me Serene” project with BIO5 Institute seed funding. Now available free via the App Store and Google Play, it aims to aid people’s mental and physical health.

Health Sciences researchers are recognized for mentoring students in the lab. Here’s a look at how one PI guides a graduate research assistant.

New research from the University of Arizona Health Sciences found that people who suffer from migraine may benefit from green light therapy, which was shown to reduce the frequency and intensity of headaches and improve patient quality of life.

In general, deciding whether to take part in an activity is “not one size fits all,” said Dr. Shad Marvasti, director of public health at the University of Arizona College of Medicine-Phoenix. He said anyone who could be considered a vulnerable individual, such as someone who has a chronic disease or compromised immune system, should consider how essential it is to take part in a potentially risky activity.

People who suffer from migraine are reducing their pain and improving their quality of life thanks to pain specialists at the University of Arizona Health Sciences and their green light research.

A study by University of Arizona Health Sciences researchers found that green light therapy resulted in about a 60% reduction in the pain intensity of the headache phase and number of days per month people experienced migraine headaches.

Many individuals recovering from COVID-19 are experiencing lingering symptoms that can last for weeks. One post-viral symptom is something called "brain fog." Dr. Shad Marvasti, an associate professor and director of public health and prevention curriculum at the University of Arizona College of Medicine in Phoenix, explains the symptoms of brain fog.

Many individuals recovering from COVID-19 are experiencing lingering symptoms that can last for weeks. One post-viral symptom is something called "brain fog." Dr. Shad Marvasti, an associate professor and director of public health and prevention curriculum at the University of Arizona College of Medicine in Phoenix, explains the symptoms of brain fog.

Dr. Victoria Maizes, executive director of the Andrew Weil Center for Integrative Medicine at the University of Arizona, discusses the “prescribing cascade” and the health risks to older adults who take multiple medications to treat different chronic conditions.